Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? - Sebti M; Schweitzer-Chaput A; Cisternino S; Hinterlang M; Ancedy D; Lam S; Auvity S; Cotteret C; Lortholary O; Schlatter J (Pharmaceuticals (Basel, Switzerland), 2024)